The Australian Competition and Consumer Commission (ACCC) announced today that it would oppose the proposed acquisition by Sonic Healthcare Limited (Sonic) of Healthscope Limited’s (Healthscope) pathology business in Queensland. The ACCC concluded that the acquisition is likely to affect competition in the market for community pathology services in Queensland.
Full Content: ACCC
Related Content: The Criminalization of Serious Cartel Conduct in Australia
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Qualcomm Reportedly Considering Acquisition of Intel’s PC Design Business
Sep 8, 2024 by
CPI
American Airlines and JetBlue Lose Bid to Dismiss Antitrust Lawsuits Over Former Alliance
Sep 8, 2024 by
CPI
Elizabeth Warren Supports DOJ Antitrust Probe Into Nvidia
Sep 8, 2024 by
CPI
Google Faces Major Antitrust Battle Over $20 Billion Ad Tech Business
Sep 8, 2024 by
CPI
UK Regulator Joins US in Antitrust Battle Against Google
Sep 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI